• Chinese medical journal · Dec 2019

    Multicenter Study Observational Study

    Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis.

    • Chun Li, Yan Zhang, Hui Song, Jie Gao, Dong-Bao Zhao, Qi Zhu, Dong-Yi He, Li Wang, Xiang-Pei Li, Xu-Dong Liu, Wei-Guo Xiao, Xin-Yu Wu, Hua-Xiang Wu, Wei Tu, Shao-Xian Hu, Xin Wang, Zhi-Jun Li, Zhi-Min Lu, Zhan-Yun Da, Bo Liang, Xiao-Min Liu, Jin-Wei Zhao, Ling Li, Feng Han, Wu-Fang Qi, Wei Wei, Xu Ma, Zhen-Bin Li, Gui-Min Zheng, Feng-Xiao Zhang, Yi Li, You-Lian Wang, Guang-Hui Ling, Jin-Wei Chen, Xiao-Qiang Hou, Jing Zhang, Qing-Ping Chen, Chang-Lian Liu, Jia-Shun Zeng, Qing-Hua Zou, Yong-Fei Fang, Yin Su, and Zhan-Guo Li.
    • Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
    • Chin. Med. J. 2019 Dec 20; 132 (24): 2899-2904.

    BackgroundClinical outcomes of undifferentiated arthritis (UA) are diverse, and only 40% of patients with UA develop rheumatoid arthritis (RA) after 3 years. Discovering predictive markers at disease onset for further intervention is critical. Therefore, our objective was to analyze the clinical outcomes of UA and ascertain the predictors for RA development.MethodsWe performed a prospective, multi-center study from January 2013 to October 2016 among Chinese patients diagnosed with UA in 22 tertiary-care hospitals. Clinical and serological parameters were obtained at recruitment. Follow-up was undertaken in all patients every 12 weeks for 2 years. Predictive factors of disease progression were identified using multivariate Cox proportional hazards regression.ResultsA total of 234 patients were recruited in this study, and 17 (7.3%) patients failed to follow up during the study. Among the 217 patients who completed the study, 83 (38.2%) patients went into remission. UA patients who developed RA had a higher rheumatoid factor (RF)-positivity (42.9% vs. 16.8%, χ = 8.228, P = 0.008), anti-cyclic citrullinated peptide (CCP) antibody-positivity (66.7% vs. 10.7%, χ = 43.897, P < 0.001), and double-positivity rate of RF and anti-CCP antibody (38.1% vs. 4.1%, χ = 32.131, P < 0.001) than those who did not. Anti-CCP antibody but not RF was an independent predictor for RA development (hazard ratio 18.017, 95% confidence interval: 5.803-55.938; P < 0.001).ConclusionAs an independent predictor of RA, anti-CCP antibody should be tested at disease onset in all patients with UA.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…